Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.

نویسندگان

  • Paulus Kirchhof
  • Gregory Y H Lip
  • Isabelle C Van Gelder
  • Jeroen Bax
  • Elaine Hylek
  • Stefan Kaab
  • Ulrich Schotten
  • Karl Wegscheider
  • Giuseppe Boriani
  • Axel Brandes
  • Michael Ezekowitz
  • Hans Diener
  • Laurent Haegeli
  • Hein Heidbuchel
  • Deirdre Lane
  • Luis Mont
  • Stephan Willems
  • Paul Dorian
  • Maria Aunes-Jansson
  • Carina Blomstrom-Lundqvist
  • Maria Borentain
  • Stefanie Breitenstein
  • Martina Brueckmann
  • Nilo Cater
  • Andreas Clemens
  • Dobromir Dobrev
  • Sergio Dubner
  • Nils G Edvardsson
  • Leif Friberg
  • Andreas Goette
  • Michele Gulizia
  • Robert Hatala
  • Jenny Horwood
  • Lukas Szumowski
  • Lukas Kappenberger
  • Josef Kautzner
  • Angelika Leute
  • Trudie Lobban
  • Ralf Meyer
  • Jay Millerhagen
  • John Morgan
  • Felix Muenzel
  • Michael Nabauer
  • Christoph Baertels
  • Michael Oeff
  • Dieter Paar
  • Juergen Polifka
  • Ursula Ravens
  • Ludger Rosin
  • W Stegink
  • Gerhard Steinbeck
  • Panos Vardas
  • Alphons Vincent
  • Maureen Walter
  • Günter Breithardt
  • A John Camm
چکیده

While management of atrial fibrillation (AF) patients is improved by guideline-conform application of anticoagulant therapy, rate control, rhythm control, and therapy of accompanying heart disease, the morbidity and mortality associated with AF remain unacceptably high. This paper describes the proceedings of the 3rd Atrial Fibrillation NETwork (AFNET)/European Heart Rhythm Association (EHRA) consensus conference that convened over 60 scientists and representatives from industry to jointly discuss emerging therapeutic and diagnostic improvements to achieve better management of AF patients. The paper covers four chapters: (i) risk factors and risk markers for AF; (ii) pathophysiological classification of AF; (iii) relevance of monitored AF duration for AF-related outcomes; and (iv) perspectives and needs for implementing better antithrombotic therapy. Relevant published literature for each section is covered, and suggestions for the improvement of management in each area are put forward. Combined, the propositions formulate a perspective to implement comprehensive management in AF.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.

There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on ...

متن کامل

Modulation of extracellular atrioventricular node field potential pattern and ventricular rhythm by morphine in experimental atrial fibrillation in isolated rabbit heart

Introduction: Endorphins are produced by cardiomyocytes, and exert different effects on the heart. The aim of the present study is to assess morphine effects on extracellular atrioventricular (AV) node field potential pattern and ventricular rhythm of isolated rabbit heart during experimental atrial fibrillation (AF). Methods: Effects of different concentrations of morphine (10, 20, 50 and 1...

متن کامل

Investigating the Effect of Inflammation on Atrial Fibrillation Occurrence by Measuring Highly Sensitive C-reactive Protein (hs-CRP)

Introduction: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmias that cardiologists and internists encounter. The goal of this article is to clarify an overview of the evidence linking inflammation to AF existence, which may highlight the effect of some pharmacological agents that have genuine potential to reduce the clinical burden of AF by modulating inflammatory pathways. Mat...

متن کامل

Update on medical management of atrial fibrillation in the modern era.

The management of atrial fibrillation involves control of the ventricular response rate, anticoagulation to reduce the risk of stroke and attempts to maintain sinus rhythm. The approach to patients with atrial fibrillation has become increasingly complex as therapeutic options have expanded. The ultimate reasons to treat atrial fibrillation include improvement in symptoms, reduction in adverse ...

متن کامل

Isolated cardiac hydatidosis.

475–480. 8. Khargi K, Hutten BA, Lemke B, Deneke T. Surgical treatment of atrial fibrillation: a systematic review. Eur J Cardiothoracic Surg 2005;27: 258–265. 9. Blomström-Lundqvist C, Johansson B, Berglin E, Nilsson L, Jensem SM, Thelin S, Holmgren A, Edvarsson N, Källner G, Blomström P. A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation i...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

دوره 14 1  شماره 

صفحات  -

تاریخ انتشار 2012